Patent US4256749A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4256749A Expired / Lapsed US ⏱️ 0.0 years remaining

Fluorine-containing 1,4-dihydropyridine compounds, pharmaceutical compositions thereof and their medicinal use

Assignee: Bayer AG
•
Filing: 1979-09-10
•
Granted: 1981-03-17
•
Expires: 1999-09-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to fluorine-containing 1,4-dihydropyridine compounds and method for their preparation. Also included are compositions containing said fluorine-containing 1,4-dihydropyridine compounds and the use of said compounds and compositions as agents for influencing circulation.

Inventors

  • 👤 Harald Horstmann
  • 👤 Friedrich Bossert
  • 👤 Arend Heise
  • 👤 Stanislav Kazda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 09:10
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/04; A; A61; A61P; A61P25/00; A61P25/08; A61P9/00; A61P9/06; A61P9/08; A61P9/10; A61P9/12; C07D211/00; C07D211/04; C07D211/80; C07D211/84; C07D211/90

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 480 words
A fluorine-containing 1,4-dihydropyridine of the formula ##STR58## or a salt thereof, in which R denotes a hydrogen atom an alkyl group having up to 8 carbon atoms or an aralkyl group which is monocyclic or bicyclic carbocyclic in the aryl portion and contains up to 8 carbon atoms in the alkyl portion, R 1 and R 6 identical or different and each denotes an alkyl group having up to 8 carbon atoms, R 4 represents alkyl having up to 8 carbon atoms or represents a monocyclic or bicyclic carbocyclic aryl radical which is optionally substituted by 1 or 2 identical or different substituents selected from nitro, cyano, trifluoromethyl, halogen, azido, trifluoromethoxy, alkyl, alkoxy, alkylmercapto and SO 2 --alkyl, each of said alkyl, alkoxy, alkylmercapto and SO 2 --alkyl groups having up to 8 carbon atoms, or denotes a quinolyl, pyridyl, pyrimidyl, thienyl or furyl radical which is optionally substituted by alkyl having up to 8 carbon atoms or halogen, R 5 denotes an alkyl group having up to 8 carbon atoms which is optionally substituted by halogen, or denotes an alkenyl, alkynyl, alkoxyalkyl or aminoalkyl group, each having up to 8 carbon atoms, it being possible for the two hydrogen atoms of the amino group to be replaced by 1 or 2 alkyl groups each having up to 8 carbon atoms and/or by an aralkyl group as defined above for R, or denotes a radical of the formula ##STR59## and R 2 and R 3 in each case are identical or different and either one of the two substituents denotes a hydrogen atom and the other substituent denotes, or each of the two substituents denotes, a straight-chain, branched or cyclic radical group having up to 8 carbon atoms or an aralkyl group which is monocyclic or bicyclic carbocyclic in the aryl portion and contains up to 8 carbon atoms in the alkyl portion which contains at least 1 perfluorinated carbon atom having 2 or 3 fluorine substituents, this alkyl radical optionally being interrupted by the group --CH 2 --X--CH 2 --, in which X denotes oxygen or sulphur, or in which R 2 and R 3 together with the CH group complete a saturated isocyclic ring which has 4 to 7 ring members and contains at least 1 perfluorinated carbon atom and is optionally substituted by an alkyl group, it being possible for this alkyl group, in turn, again to contain 1 or 2 perfluorinated carbon atoms. in which X denotes oxygen or sulphur, or in which R 2 and R 3 together with the CH group completes a saturated isocyclic radical which has 4 to 7 ring members and contains 1, 2 or 3 perfluorinated carbon atoms and is optionally substituted by an alkyl group with 1 to 4 carbon atoms, it being possible for this alkyl group, in turn, again to contain one or two perfluorinated carbon atoms.
Claim 2
Dependent Claim 480 words
A fluorine-containing 1,4-dihydropyridine of the formula ##STR58## or a salt thereof, in which R denotes a hydrogen atom an alkyl group having up to 8 carbon atoms or an aralkyl group which is monocyclic or bicyclic carbocyclic in the aryl portion and contains up to 8 carbon atoms in the alkyl portion, R 1 and R 6 identical or different and each denotes an alkyl group having up to 8 carbon atoms, R 4 represents alkyl having up to 8 carbon atoms or represents a monocyclic or bicyclic carbocyclic aryl radical which is optionally substituted by 1 or 2 identical or different substituents selected from nitro, cyano, trifluoromethyl, halogen, azido, trifluoromethoxy, alkyl, alkoxy, alkylmercapto and SO 2 --alkyl, each of said alkyl, alkoxy, alkylmercapto and SO 2 --alkyl groups having up to 8 carbon atoms, or denotes a quinolyl, pyridyl, pyrimidyl, thienyl or furyl radical which is optionally substituted by alkyl having up to 8 carbon atoms or halogen, R 5 denotes an alkyl group having up to 8 carbon atoms which is optionally substituted by halogen, or denotes an alkenyl, alkynyl, alkoxyalkyl or aminoalkyl group, each having up to 8 carbon atoms, it being possible for the two hydrogen atoms of the amino group to be replaced by 1 or 2 alkyl groups each having up to 8 carbon atoms and/or by an aralkyl group as defined above for R, or denotes a radical of the formula ##STR59## and R 2 and R 3 in each case are identical or different and either one of the two substituents denotes a hydrogen atom and the other substituent denotes, or each of the two substituents denotes, a straight-chain, branched or cyclic radical group having up to 8 carbon atoms or an aralkyl group which is monocyclic or bicyclic carbocyclic in the aryl portion and contains up to 8 carbon atoms in the alkyl portion which contains at least 1 perfluorinated carbon atom having 2 or 3 fluorine substituents, this alkyl radical optionally being interrupted by the group --CH 2 --X--CH 2 --, in which X denotes oxygen or sulphur, or in which R 2 and R 3 together with the CH group complete a saturated isocyclic ring which has 4 to 7 ring members and contains at least 1 perfluorinated carbon atom and is optionally substituted by an alkyl group, it being possible for this alkyl group, in turn, again to contain 1 or 2 perfluorinated carbon atoms. in which X denotes oxygen or sulphur, or in which R 2 and R 3 together with the CH group completes a saturated isocyclic radical which has 4 to 7 ring members and contains 1, 2 or 3 perfluorinated carbon atoms and is optionally substituted by an alkyl group with 1 to 4 carbon atoms, it being possible for this alkyl group, in turn, again to contain one or two perfluorinated carbon atoms.
Claim 3
Dependent Claim 336 words
A compound according to claim 1, in which R denotes a hydrogen atom, an alkyl group with 1 or 2 carbon atoms or a benzyl radical, R 1 and R 6 are identical or different and each denotes an alkyl group with 1 to 4 carbon atoms, R 4 denotes a phenyl radical, which is optionally substituted by one or two substituents selected from nitro, cyano, trifluoromethyl, halogen, azido, trifluoromethoxy, alkyl, alkoxy, alkylmercapto and SO 2 --alkyl, in each case with 1 or 2 carbon atoms in the alkyl and alkoxy radicals, or denotes a pyridyl radical, R 5 denotes an alkyl group with 1 to 6 carbon atoms, which is optionally substituted by halogen, or denotes an alkoxyalkyl, alkenyl or alkynyl group with up to 6 carbon atoms or denotes an aminoalkyl group with 1 to 4 carbon atoms in the alkyl radical, it being possible for the two hydrogen atoms of the amino group to be replaced by 1 or 2 alkyl groups with 1 to 4 carbon atoms and/or by a benzyl group, or denotes a radical of the formula ##STR60## and R 2 and R 3 in each case are identical or different and either one of the two substituents can denote hydrogen and the other substituent denotes, or the two substituents denote, a straight-chain, branched or cyclic alkyl radical which has up to 8 carbon atoms and contains 1, 2 or 3 perfluorinated carbon atoms with in each case, 2 or 3 fluorine substituents, this alkyl radical being optionally interrupted by the grouping --CH 2 --X--CH 2 --, in which X denotes oxygen or sulphur, or in which R 2 and R 3 together with the CH group completes a saturated isocyclic radical which has 4 to 7 ring members and contains 1, 2 or 3 perfluorinated carbon atoms and is optionally substituted by an alkyl group with 1 to 4 carbon atoms, it being possible for this alkyl group, in turn, again to contain one or two perfluorinated carbon atoms.
Claim 4
Dependent Claim 68 words
A compound according to claim 2, in which R 2 and/or R 3 denote a straight-chain, branched or cyclic alkyl radical with having up to 6 carbon atoms, and contains 1, 2 or 3 perfluorinated carbon atoms with having in each case, 2 or 3 fluorine substituents, said alkyl radical being optionally interrupted by the grouping --CH 2 --X--CH 2 -- in which X denotes oxygen or sulphur.
Claim 5
Dependent Claim 16 words
A compound according to claim 1 or 2 wherein each halogen is chlorine bromine or fluorine.
Claim 6
Dependent Claim 28 words
A pharmaceutical composition containing as an active ingredient a circulation influencing amount of compound according to claim 1 in admixture with a solid liquid or liquefied gaseous diluent.
Claim 7
Dependent Claim 33 words
A pharmaceutical composition of claim 5 containing as an active ingredient a circulation influencing amount of a compound according to claim 5 in the form of a sterile or physiologically isotonic aqueous solution.
Claim 8
Dependent Claim 18 words
A composition according to claim 5 containing from 0.5 to 90% by weight of the said active ingredient.
Claim 9
Dependent Claim 24 words
A medicament in dosage unit form comprising a circulation influencing amount of a compound according to claim 1 together with an inert pharmaceutical carrier.
Claim 10
Dependent Claim 16 words
A medicament of claim 8 in the form of tablets, pills, dragees, capsules, ampoules, or suppositories.
Claim 11
Dependent Claim 42 words
A method of combating circulatory diseases in warm-blooded animals which comprises administering to the animals a circulation influencing amount of an active compound according to claim 1 either alone or in admixture with a diluent or in the form of a medicament.
Claim 12
Dependent Claim 28 words
A method according to claim 10 in which the active compound is administered intravenously in an amount of 0.001 to 1 mg per kg body weight per day.
Claim 13
Dependent Claim 28 words
A method according to claim 10 in which the active compound is administered intravenously in an amount of 0.005 to 0.1 mg per ky body weight per day.
Claim 14
Dependent Claim 28 words
A method according to claim 10 in which the active compound is administered orally in an amount of 0.005 to 10 mg per kg body weight per day.
Claim 15
Dependent Claim 28 words
A method according to claim 10 in which the active compound is administered orally in an amount of 0.05 to 5 mg per ky body weight per day.
Claim 16
Dependent Claim 9 words
A compound according to claim 1 which is 3-ethoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-5-trifluoroethoxycarbonyl-1,4-dihydropyridine.
Claim 17
Dependent Claim 9 words
A compound according to claim 1 which is 2,6-dimethyl-3-β-methoxyethoxycarbonyl-4-(3-nitrophenyl)-5-trifluoroethxycarbonyl-1,4-dihydropyridine.
Claim 18
Dependent Claim 9 words
A compound according to claim 1 which is 2,6-dimethyl-3,5-bis-trifluoroethoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine.
Claim 19
Dependent Claim 9 words
A compound according to claim 1 which is 2,6-dimethyl-3,5-bis-trifluoroethoxycarbonyl-4-(2-trifluorophenyl)-1,4-dihydropyridine.
Claim 20
Dependent Claim 9 words
A compound according to claim 1 which is 2,6-dimethyl-3-methoxycarbonyl-4-(2-trifluorophenyl)-5-trifluoroethoxycarbonyl-1,4-dihydropyridine.

References Cited (Backward Citations)

US4044141A Cited
US4145432A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-03-16 1984-09-15 1985-03-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-03-16 1988-09-15 1989-03-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-03-16 1992-09-15 1993-03-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag